Skip to content

Prospective Randomized Clinical Trial Comparing Outcomes of Secondary Intention Wound Care Methods

Prospective Randomized Clinical Trial Comparing Outcomes of Secondary Intention Wound Care Methods

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03880331
Enrollment
8
Registered
2019-03-19
Start date
2019-12-03
Completion date
2021-03-01
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Surgical, Wound Heal

Keywords

Secondary intention, Wound care methods

Brief summary

This is a randomized controlled trial which is designed to determine whether aggressive and frequent debridement of an acute post-surgical wound shortens healing time.

Detailed description

Secondary intention is an established method of allowing post-surgical defects to heal. Previous studies have shown a positive association between the frequency of debridement and healing rates in chronic wounds. However, the effect of debridement on acute, post-surgical wounds is not well-described in the literature. This randomized controlled trial is designed to determine whether aggressive and frequent debridement of an acute post-surgical wound shortens healing time.

Interventions

PROCEDUREDebridement

Aggressive vs Minimal Debridement

Sponsors

Lahey Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Blinded investigator will assess photographs of completely healed wounds

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Dermatology patients at Lahey Clinic: 2. who have undergone Mohs surgery or excision 3. who are older than 18 years 4. who are able to give consent 5. who had postoperative defects allowed to heal by secondary intention on the a) head and neck, b) trunk and upper extremities, c) lower extremities 6. who are willing and able to return to clinic in Peabody, MA, for all wound care visits

Exclusion criteria

1. Unable to consent (due to language barrier or mental status) 2. Unable to perform daily wound care 3. Unwilling or unable to return for follow-up 4. Have baseline venous stasis or pitting edema of the affected limb 5. Wear compression stockings or require use of a compressive bandage (such as an Unna Boot) at baseline.

Design outcomes

Primary

MeasureTime frameDescription
Time to healing0-16 weeksTime to complete healing as determined by one of the study investigators

Secondary

MeasureTime frameDescription
Patient satisfaction with scar: Patient Scar Assessment Questionnaire (PSAQ)0-16 weeks. NOTE: The PSAQ will be completed by the patient once their wound is determined to be completely healed by the study investigators; usually between 6-8 weeks.As assessed by the Patient Scar Assessment Questionnaire (PSAQ), a validated questionnaire used standardly in Dermatology for assessing patient-based outcome measures of scarring. It consists of 5 subscales: appearance, symptoms consciousness, satisfaction with appearance and satisfaction with symptoms. Each subscale consists of a set of items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favorable category and 4 assigned to the least favorable). It has been demonstrated to be a reliable and valid measure of patients' perception of scarring. See reference #12 in reference list for more information.
Cosmetic Appearance0-16 weeks. NOTE: A photograph of the the patient's final healed wound will be evaluated by a blinded investigator after the wound is determined to be completely healed by the study investigators; usually between 6-8 weeksAs assessed by the Visual Analog Scale, a validated image-based scale, that uses photographs for evaluation in 5 dimensions (pigmentation, vascularity, acceptability, observer comfort, and contour). Observer comfort measures the observer's comfort level when viewing the wound. The benefit of using this scale for the purposes of the study is because it is a photograph-based scale which can be evaluated later by a blinded physician rather than in the clinic at the time of the visit. The observer places a mark along a continuous line that measures 10cm long, and then that is measured from left to right and a corresponding score is given corresponding to that length (between 0 and 10). The individual scores are tallied to obtain a single overall score ranging from poor to excellent. See reference #13 in reference list for more information.
Number of required debridements0-16 weeksNumber of required debridements over the course of healing
Number of treatment failuresThrough study completion, an average of 6-8 weeksNumber of wounds that do not heal by 16 weeks
Complications0-16 weeksIncluding degree of pain (on a scale of 0-10), number of episodes of bleeding, number of infection, and incidence of tumor recurrence

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026